REFERNCES
1. Agaimy A, Koch M, Lell M, et al. SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma. Am J Surg Pathol . 2014;38(9):1274-1281. doi:10.1097/PAS.0000000000000236
2. Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI-1) Deficient Carcinomas of the Sinonasal Tract. Am J Surg Pathol . 2014;38(9):1282-1289. doi:10.1097/PAS.0000000000000285
3. Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch Int J Pathol . 2015;467(6):649-656. doi:10.1007/s00428-015-1853-1
4. El-Naggar AK. WHO classification of head and neck tumours. No Title . Accessed March 17, 2024. https://cir.nii.ac.jp/crid/1130000797841192192
5. Lee VHF, Tsang RKY, Lo AWI, et al. SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes. Cancers . 2022;14(13):3285. doi:10.3390/cancers14133285
6. Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg . 1980;2(6):497-508. doi:10.1002/hed.2890020610
7. Kohashi K, Oda Y. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Cancer Sci . 2017;108(4):547-552. doi:10.1111/cas.13173
8. Hornick JL, Dal Cin P, Fletcher CDM. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol . 2009;33(4):542-550. doi:10.1097/PAS.0b013e3181882c54
9. Agaimy A, Hartmann A, Antonescu CR, et al. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. Am J Surg Pathol . 2017;41(4):458-471. doi:10.1097/PAS.0000000000000797
10. Kakkar A, Antony VM, Pramanik R, Sakthivel P, Singh CA, Jain D. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns. Hum Pathol . 2019;83:59-67. doi:10.1016/j.humpath.2018.08.008
11. Gomez-Acevedo H, Patterson JD, Sardar S, et al. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion. BMC Cancer . 2019;19(1):827. doi:10.1186/s12885-019-6043-0
12. Shah AA, Jain D, Ababneh E, et al. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features. Head Neck Pathol . Published online January 1, 2019. doi:10.1007/s12105-019-01065-7
13. Chung SY, Kenee P, Mitton T, Halderman A. SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity. J Neurol Surg Rep . 2023;84(1):e1-e5. doi:10.1055/a-1996-1283
14. Shaverdashvili K, Azimi‐Nekoo E, Cohen P, et al. INI‐1 (SMARCB1)–Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies. The Oncologist . 2020;25(9):738-744. doi:10.1634/theoncologist.2019-0830
15. Chitguppi C, Rabinowitz MR, Johnson J, et al. Loss of SMARCB1 Expression Confers Poor Prognosis to Sinonasal Undifferentiated Carcinoma. J Neurol Surg Part B Skull Base . 2020;81(6):610-619. doi:10.1055/s-0039-1693659
16. Trieu V, Aulet RM, Ciolino A, Rimash T. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.Ann Otol Rhinol Laryngol . 2019;128(7):676-680. doi:10.1177/0003489419836668
17. Vaziri Fard E, Zhang S, Cai Z, et al. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.Hum Pathol . 2019;89:62-70. doi:10.1016/j.humpath.2019.04.008